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ABSTRACT 
Objective: The objective of the present study is to develop simple, rapid, sensitive, accurate and economic stability-indicating ultra-performance 
liquid chromatographic (UPLC) method for the simultaneous quantification of phenylephrine hydrochloride, chlorpheniramine maleate, 
paracetamol, guaiphenesin and bromhexine hydrochloride in bulk and tablet dosage form. 
Methods: The separation of drugs in the chromatographic column was accomplished on Hibar C18 (100 mm x 2.1 mm, 1.6 µm) column at a detection 
wavelength of 220 nm. The mobile phase was a combination of sodium phosphate monobasic monohydrate buffer (pH was adjusted to 3.5 with 
orthophosphoric acid) and acetonitrile in the ratio of 70:30 % v/v which was pumped at a flow rate of 0.3 ml/min. The column temperature was 
maintained at 30 °C and the injection volume was 0.3 µl. Forced degradation studies of drugs were carried out using acid, base, peroxide, light and heat.  
Results: All the five drugs have been eluted within 3 min. The retention times were found to be 0.834 min, 1.199 min, 1.600 min, 1.979 min and 
2.525 min for phenylephrine, chlorpheniramine maleate, paracetamol, guaiphenesin and bromhexine respectively. The correlation coefficient (r2) 
was found to be 0.999 for all the drugs. The recovery levels were found to be in the range of 98.06 % to 100.28 %. RSD values of drugs were found to 
be below 2 %. The results of limit of detection and quantitation specified the sensitivity of the developed method. Significant degradation of drugs as 
a result of stress studies was found in acid, base and peroxide, but they were slightly degraded in photolytic and thermal conditions. The method has 
effectively resolved the degraded products. All the validation parameters were found to be within the limits according to International Conference 
on Harmonization (ICH) guidelines.  
Conclusion: A simple and rapid UPLC method was established for the determination of five drugs. Hence, the proposed method can be employed for 
the quality control of specified drugs in bulk and pharmaceutical formulation even in the presence of degradation products. 
Keywords: Phenylephrine hydrochloride, Chlorpheniramine maleate, Paracetamol, Guaiphenesin, Bromhexine hydrochloride, Stability indicating 
UPLC method 




Phenylephrine hydrochloride [fig. 1] is chemically 3-[(1R)-1-
hydroxy-2-(methylamino) ethyl] phenol hydrochloride is a 
sympathomimetic amine that acts predominantly on α-adrenergic 
receptors and it is mainly used to treat nasal congestion.  
 
 
Fig. 1: Structure of phenylephrine hydrochloride 
 
Chlorpheniramine maleate [fig. 2] is chemically but-2-enedioic acid; 
3-(4-chlorophenyl)-N, N-dimethyl-3-pyridine-2-ylpropan-1-amine is 
a histamine H1-receptor antagonist used in allergic reactions, hay 
fever, rhinitis, urticaria and asthma. 
Paracetamol [fig. 3] is chemically N-(4-hydroxyphenyl) acetamide is 
a p-aminophenol derivative is commonly used for its analgesic and 
antipyretic effects. 
 
Fig. 2: Structure of chlorpheniramine maleate 
 
 
Fig. 3: Structure of paracetamol 
 
Guaiphenesin [fig. 4] is chemically 3-(2-methoxyphenyl) propane-
1,2-diol is an expectorant and also has some muscle relaxing action. 
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Fig. 4: Structure of guaiphenesin 
 
Bromhexine hydrochloride [fig. 5] is chemically 2,4-dibromo-6-
[[cyclohexyl(methyl) amino]methyl] aniline; hydrochloride act as an 
expectorant or mucolytic agent. 
 
 
Fig. 5: Structure of bromhexine hydrochloride 
 
The combination of phenylephrine hydrochloride, chlorpheniramine 
maleate, paracetamol, guaiphenesin and bromhexine hydrochloride 
is available as tablets in the market till date which is used to treat 
cough, fever, cephalalgia, cold, catarrh, flu, hay fever and allergies 
due to food. Extensive literature survey revealed various analytical 
techniques for the estimation of mentioned drugs individually [1] 
and with other combinations [2-14]. An RP-HPLC method has been 
reported for the simultaneous estimation of phenylephrine 
hydrochloride, chlorpheniramine maleate, paracetamol, 
guaiphenesin and bromhexine hydrochloride in bulk and tablet 
dosage form [15]. In this method the retention time of analytes was 
high with a run time of 35 min thereby increasing the solvent 
consumption and leading to longer analysis time. The mode of 
separation was gradient and has used two mobile phases one of 
which was a combination of potassium dihydrogen phosphate buffer 
with octane-1-sulphonic acid reagent. Usage of buffers reduces the 
life of the column and preparation of mobile phases consumes more 
time, thereby increasing the analysis time. Hence, a rapid method is 
needed for the estimation of these drugs which can be attained by 
using UPLC technique with high sensitivity and less time of analysis. 
In addition to this, no UPLC method has been reported for the assay 
of specified drugs either individually or simultaneously in bulk and 
pharmaceutical formulation. Therefore, it was thought appropriate 
to develop stability-indicating ultra-performance liquid 
chromatographic procedure that serves as a rapid, simple, accurate, 
and sensitive method for the simultaneous estimation of 
phenylephrine hydrochloride, chlorpheniramine maleate, 
paracetamol, guaiphenesin and bromhexine hydrochloride in bulk 
and tablet dosage form. Further, it was aimed to validate the 
developed method as per validation of analytical procedures i.e. ICH 
guidelines: Q2[R1] Validation of Analytical Procedures: Text and 
Methodology. 
MATERIALS AND METHODS 
Chemicals and reagents 
The commercially available formulation (Kuff Q NF tablets) 
containing phenylephrine hydrochloride 10 mg, chlorpheniramine 
maleate 2 mg, paracetamol 325 mg, guaiphenesin 100 mg and 
bromhexine hydrochloride 8 mg, manufactured by Intas 
Pharmaceuticals Limited were purchased from local pharmacy. 
Standard drugs were obtained from Spectrum Pharma Research 
Solutions, Hyderabad. Orthophosphoric acid, acetonitrile of 
analytical reagent grade and HPLC grade water was purchased from 
Rankem. Sodium phosphate monobasic monohydrate of AR grade 
was purchased from Sisco research laboratories. 
Instrument and equipment 
Acquity UPLC H-Class system (Waters) consists of a binary solvent 
manager, autosampler with UV detector. The output signal was 
monitored and processed using empower 2 software. Sonicator 
(LMUC-2, Labman scientific), pH meter (AD 1020, ADWA) and 
analytical balance (ER-200A, AFCOSET) were used. 
Chromatographic conditions 
The chromatographic column used was Hibar C18 (100 mm x 4.6 
mm x 1.8 µm). The separation was achieved on isocratic mode. The 
mobile phase consists of sodium phosphate monobasic 
monohydrate buffer whose pH was adjusted to 3.5 with 
orthophosphoric acid and acetonitrile in the ratio of 70:30 %v/v was 
pumped at a flow of 0.3 ml/min. The column temperature was 
maintained at 30 °C with an injection volume of 0.3 µl and the 
detector was monitored at 220 nm with a total run time of 5 min. 
Preparation of buffer solution 
The buffer solution of 50 mmol sodium phosphate monobasic 
monohydrate was prepared by weighing 6.89 g of sodium phosphate 
monobasic monohydrate and transferred into 1000 ml volumetric 
flask. About 950 ml of milli-Q water was added, degassed and 
sonicated for 20 min and finally, the volume was made up with 
water then the pH was adjusted to 3.5 with orthophosphoric acid. 
Preparation of diluent 
The diluent was prepared by taking water and acetonitrile in the 
ratio 50:50. 
Preparation of standard solution 
The standard stock solution was prepared by weighing 2.5 mg of 
phenylephrine hydrochloride, 0.5 mg of chlorpheniramine maleate, 
81.25 mg paracetamol, 25 mg of guaiphenesin and 2 mg of 
bromhexine hydrochloride and transferred to 25 ml volumetric 
flask. To this 10 ml of diluent was added, sonicated for 25 min and 
the volume was made up with diluent. From the above standard 
stock solution 1 ml was transferred into 10 ml volumetric flask and 
made up to the volume with diluent so as to get final concentration 
of 10 μg/ml of phenylephrine hydrochloride, 2 μg/ml of 
chlorpheniramine maleate, 325 μg/ml of paracetamol, 100 μg/ml of 
guaiphenesin and 8 μg/ml of bromhexine hydrochloride. 
Preparation of sample solution 
From the blend of 20 tablets, the weight of powder equivalent to one 
tablet was transferred into a 100 ml volumetric flask, to this 50 ml of 
diluent was added and sonicated for 25 min; further the volume was 
made up with diluent and filtered. From the filtered solution 1 ml 
was transferred into 10 ml volumetric flask and made up to the 
volume with diluent. 
Preparation of samples for forced degradation 
During stress studies, degradation in acidic medium was carried out 
by taking 1 ml of standard stock solution, to this 1 ml of 1 N HCl was 
added and refluxed for 30 min at 60 °C. The resultant solution was 
neutralized by adding 1 ml of 1 N NaOH solution and diluted to 10 
ml with diluent. Forced degradation in the basic medium was 
performed by taking 1 ml of standard stock solution, to this 1 ml of 1 
N NaOH was added and refluxed for 30 min at 60 °C. The resultant 
solution was neutralized using 1 N HCl solution and diluted to 10 ml 
with diluent. For oxidative degradation, 1 ml of 10 % hydrogen 
peroxide was added to 1 ml of standard stock solution. The solution 
was kept for 30 min at 60 °C. The resultant solution was diluted to 
10 ml with diluent. For thermal degradation, the standard stock 
solution was taken in a beaker and placed in oven at 60 °C for 6 h 
and 1 ml from the resultant solution was diluted to 10 ml with 
diluent. For photostability studies, a volume of 5 ml from stock 
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solution was taken in a beaker and kept under UV light in UV 
chamber for 3 d. From the resultant solution 1 ml was taken and 
diluted up to 10 ml with diluent. 
Method validation 
The developed method was validated for specificity, accuracy, 
precision, linearity, limit of detection (LOD), the limit of quantitation 
(LOQ) and robustness according to ICH guidelines [16]. 
Specificity 
Specificity of the method was performed to analyse the interference 
of solvent and impurities with the analyte peaks. To determine this, 
blank and generated impurities by forced degradation were injected 
into the chromatographic system and observed for any interfering 
peaks at the retention time of analytes peak. 
Accuracy 
Accuracy was performed to ensure the reliability and accuracy of the 
method by recovery studies which was carried out by standard 
addition method. The known quantities of pure drugs were added to 
the pre-analyzed sample at three concentration levels 50 %, 100 %, 
150 % in three replicates and contents were reanalyzed by the 
proposed method and the percent recovery were calculated. 
Precision 
Precision was performed to check the repeatability of the developed 
method. The standard solution was prepared at working 
concentration and injected six times into the chromatographic 
system. The percentage relative standard deviation was calculated.  
Linearity 
The linearity of the method was determined by preparing the 
solutions at five different concentration levels with standard drugs, 
which was from 25 % to 150 % of target assay concentration. The 
calibration curves were plotted between peak area and 
concentration. The least square linear regression were carried and 
correlation coefficient (r2) values were observed to check the 
linearity.  
Limit of detection (LOD) and limit of quantitation (LOQ) 
LOD is the minimum concentration at which analyte can be detected 
and calculated from the linearity curve by applying the formula:  
LOD = 3.3 × SD/S 
LOQ is the lowest concentration of the analyte that can be estimated 
quantitatively by applying the formula:  
LOQ = 10 × SD/S 
Where SD=Standard deviation of y-intercepts; S=Slope of the 
calibration curve. 
Robustness  
Robustness of the developed method was established by 
deliberately changing the method parameters such as flow rate (±0.1 
ml/min), column temperature (±5˚C) and mobile phase ratio (±5 %) 
to evaluate the impact of these conditions on the method and the 
system suitability parameters were evaluated for the studies. 
Forced degradation studies 
Forced degradation or stress testing was undertaken to demonstrate 
specificity during the development of stability-indicating assay 
method. It is the specific one, which evaluates the drug in the 
presence of its degradation products. The percentage of drug 
degraded under stressed conditions was calculated and also 
observed for the interference of degraded products peak at the 
retention times of analyte peaks.  
RESULTS AND DISCUSSION 
Method development 
After many trials made by altering the chromatographic conditions 
like mobile phase, pH of the selected mobile phases, detection 
wavelengths and injection volume to resolve all the five drugs, the 
obtained peaks were sharp with good resolution using a mobile 
phase of sodium phosphate monobasic monohydrate buffer, pH 
adjusted to 3.5 with orthophosphoric acid and acetonitrile in the 
ratio 70:30 %v/v which was pumped at a flow rate of 0.3 ml/min 
and at a detection wavelength 220 nm. The corresponding optimized 
chromatogram obtained for a standard solution of analytes was 
shown [fig. 6]. The system suitability parameters such as theoretical 
plates, resolution, tailing factor were determined and presented in 
the table 1 and the parameters were found to be within limits. All 
the drugs were eluted within 3 min with isocratic mode which 
specify an absolute rapidity of the method when compared to the 
reported RP-HPLC method where the elution of drugs took up to 25 
min on gradient mode [15]. 
 
 
Fig. 6: Typical chromatogram of standards 
 
Table 1: Results of system suitability studies 
Drug name Retention time* (min) Resolution* Plate count* Tailing factor* Peak area* 
Phenylephrine 0.834±0.03 - 6576.1±173.7 1.3±0.01 96250±544.5 
Chlorpheniramine maleate 1.199±0.10 4.2±0.2 3164.8±451.6 1.1±0.14 31280±220.7 
Paracetamol 1.600±0.10 4.4±0.1 4795.6±81.1 1.2±0.03 1938223±15007.9 
Guaiphenesin 1.979±0.01 3.6±0.1 5048.3±175.2 1.1±0.01 683832±1809.6 
Bromhexine 2.525±0.02 4.5±0.1 6379.3±96.7 1.1±0.01 387727±2718.4 
*Each value is represented as a mean±SD of 6 observations 
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After the injection of blank and degradation samples into the 
chromatographic system, no interfering peaks have been observed 
at the retention times of analyte peaks. Hence, the method was 
found to be specific for the estimation of drugs. 
Accuracy  
The results of accuracy were presented in table 2. Recovery studies 
were carried out at three concentration levels for three times each. 
From the accuracy data, it was found that the recoveries were within 
the specified range. The results of accuracy decisively specify that 
the recovery values were within the acceptance range of 98-102 %. 
Hence, the developed method was accurate for the determination of 
the above mentioned drugs. 
Precision 
From the results of precision studies which were tabulated in table 
3, the RSD values for peak areas were found to be less than 2 %. 
This surely assures that the developed method was precise and 
repeatable.
 
Table 2: Results of accuracy studies 
Name of the analyte Accuracy level (%) *Concentration spiked (μg/ml) * Concentration found (μg/ml) *Mean  
% recovery 




























































*Average of triplicate determinations, Acceptence criteria: % recovery must be 98%-102% 
 
Table 3: Results of precision studies 
Name of the analyte RSD* (%) 
Phenylephrine 0.2 




*RSD values for six determinations, RSD: Relative Standard Deviation, Acceptance criteria: RSD =<2 % 
 
Linearity and range 
The results of linearity were given in table 4 and the representative 
calibration plots were shown [fig. 7-11]. The data was treated by least-
square linear regression analysis and the correlation coefficients for all 
the drugs was found to be 0.999 over the specified range of 25-150 % 
of target assay concentrations. The results indicate linear and directly 
proportional relationship between the concentration of specified 
range and response which meet the method validation acceptance 
criteria (r2 must be 0.990-1) and hence the method was said to be 
linear for the specified concentration range. 
LOD and LOQ 
By applying the formula method, the LOD values were found to be 
0.06 µg/ml for phenylephrine, 0.03 µg/ml for chlorpheniramine 
maleate, 1.06 µg/ml for paracetamol, 0.89 µg/ml for guaiphenesin 
and 0.09 µg/ml for bromhexine. The LOQ values were found to be 
0.17 µg/ml for phenylephrine, 0.08 µg/ml for chlorpheniramine 
maleate, 3.22 µg/ml for paracetamol, 2.71 µg/ml for guaiphenesin 
and 0.28 µg/ml for bromhexine. The results of LOD and LOQ 
perfectly indicate the sensitivity of the developed UPLC method. 
Robustness 
The degraded sample solutions were prepared as per the test 
method and injected at different variable conditions, system 
suitability parameters were assessed. The results of robustness was 
presented in table 5 and 6, it was found that the parameters such as 
tailing factor, plate count were within the limits even after small but 
deliberate alterations. From the results, it was concluded that even 
small changes that have made in the chromatographic conditions did 
not affect significantly on system suitability parameters and found to 
be within limits. Hence, the developed method was robust. 
 
Table 4: Results of linearity 
Name of the analyte  Linearity range (µg/ml) Correlation coefficient (r2) 
Phenylephrine 2.5-15 0.999 
Chlorpheniramine maleate 0.5-3 0.999 
Paracetamol 81.25-487.5 0.999 
Guaiphenesin 25-150 0.999 
Bromhexine 2-12 0.999 
Acceptance criteria: Correlation coefficient (r2) must be from 0.999-1 
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Fig. 7: Calibration plot of phenylephrine 
 
 
Fig. 8: Calibration plot of chlorpheniramine maleate 
 
 
Fig. 9: Calibration plot of paracetamol 
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Fig. 10: Calibration plot of guaiphenesin 
 
 
Fig. 11: Calibration plot of bromhexine 
 
Table 5: Results of robustness for phenylephrine and chlorpheniramine maleate 
Parameter Phenylephrine  Chlorpheniramine maleate  
Tailing* Plate count# Tailing* Plate count# 
Less flow rate (0.2 ml/min) 1.42 6589 1.08 3195 
More flow rate (0.4 ml/min) 1.38 6482 1.11 2451 
Less column temperature (25 ° C) 1.41 6465 1.22 3077 
More column temperature (35 ° C) 1.40 6781 1.05 2607 
Less organic phase (75:25) 1.32 6467 1.53 1681 
More organic phase (65:35) 1.17 6752 1.12 2187 
Acceptance criteria: *Tailing: <2, #Plate count: >2000 
 
Table 6: Results of robustness for paracetamol, guaphenesin and bromhexine 
Parameter Paracetamol Guaiphenesin Bromhexine 
Tailing* Plate count# Tailing* Plate count# Tailing* Plate count# 
Less flow rate (0.2 ml/min 1.21 5195 1.16 5535 1.12 6676 
More flow rate (0.4 ml/min) 1.19 4695 1.14 5360 1.14 6182 
Less column temperature (25 ° C) 1.21 4880 1.14 5285 1.10 6340 
More column temperature (35 ° C) 1.19 4632 1.09 5213 1.07  6765 
Less organic phase (75:25) 1.12 5032 1.10 5446 1.07 7070 
More organic phase (65:35) 1.22 5129 1.07 5346 1.12 6554 
Acceptance criteria: *Tailing: <2, #Plate count: >2000 
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Forced degradation studies 
Standard and degraded samples were injected into the system with a 
run time of 10 min and the results were given in table 7. The 
degradation assay chromatograms were shown [fig. 12-16]. The 
percentage of drug degraded in solution was calculated. The 
degradation products produced as a result of stress studies did not 
interfere with the detection of analytes. Significant degradation was 
found in the presence of acid, base and peroxide. It was found that 
the drugs were slightly degraded in photolytic and thermal 




Fig. 12: Chromatogram of acid degradation 
 
 
Fig. 13: Chromatogram of base degradation 
 
 
Fig. 14: Chromatogram of peroxide degradation 
 
 
Fig. 15: Chromatogram of thermal degradation 
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Fig. 16: Chromatogram of photodegradation 
 
Table 7: Results of forced degradation studies 
Stress conditions Phenylephrine Chlorpheniramine maleate Paracetamol Guaiphenesin Bromhexine 
% Degraded 
Acid 4.60 5.50 4.56 5.09 5.85 
Base 3.91 4.72 3.73 4.27 4.99 
Peroxide 3.64 3.82 3.06 3.78 3.44 
Thermal 2.82 2.36 2.23 2.36 2.66 
Photolysis  1.81 1.91 1.80 1.91 1.33 
 
Assay of marketed formulation 
The applicability of the developed method was verified by assaying 
the marketed formulation. Kuff Q NF tablets were analyzed by 
standard comparison method. The prepared standard and sample 
solutions were injected into the chromatographic system and the 
amount of drug present in the formulation was calculated and the 
results were tabulated in table 8. The results complied with the label 
claim and specify that the developed method was successfully 
applied for quality control of formulation. 
 
Table 8: Results of assay of formulation 
S. No. Phenylephrine Chlorpheniramine maleate Paracetamol  Guaiphenesin  Bromhexine  
% Assay 
1 99.86 99.83 99.63 99.93 99.22 
2 99.90 99.66 99.32 99.25 100.59 
3 99.95 99.45 99.05 99.87 99.61 
4 99.85 99.67 99.86 99.10 99.49 
5 99.86 100.53 100.87 99.06 99.91 
6 100.48 99.84 99.58 99.38 100.35 
Mean 99.98 99.83 99.72 99.43 99.86 
 Acceptance criteria: % Assay must be in the range of 98-102 % 
 
CONCLUSION 
The developed isocratic, reverse phase UPLC method was found to be 
rapid, simple, accurate, precise and stability-indicating for the 
simultaneous estimation of phenylephrine hydrochloride, 
chlorpheniramine maleate, paracetamol, guaiphenesin and 
bromhexine hydrochloride in bulk and pharmaceutical formulation. 
The method can be used to estimate the drugs either individually or 
simultaneously in bulk and pharmaceutical formulation. This method 
has effectively resolved all the drugs and their degradation products. 
Thus, it was found to be more specific and selective for the estimation 
of above-specified drugs. The flow of mobile phase was set at very low 
rate, and has very less elution time and hence the method has 
advantages of less solvent consumption and faster analysis. Therefore, 
the developed method can be considered as economic for the 
estimation of five drugs simultaneously. Finally, it was concluded that 
the developed analytical method can be employed for the routine 
quality control of drugs in bulk and pharmaceutical formulation even 
in the presence of degraded impurities.  
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